Abstract

(Applicant's Description) The proposed Cancer Research Network (CRN) consists of research programs, enrollee populations and databases of 10 HMO Research Network members - Group Health Cooperative of Puget Sound, Harvard- Pilgrim Health Care, Henry Ford Health System, Health Partners Research Foundation, Fallon Health Care System represented by the Meyers Primary Care Institute, and Kaiser Permanente divisions in Hawaii, Oregon, Washington, Northern and Southern California, and the Rocky Mountain area. The goal of the CRN is to determine and improve the effectiveness of cancer control interventions that span the natural history of major cancers among diverse populations and health systems. The 10 HMOs, with approximately nine million enrollees, are distinguished by their longstanding commitment to prevention and research, and collaboration among themselves and affiliated academic institutions.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA079689-02
Application #
6137693
Study Section
Special Emphasis Panel (ZCA1-RLB-K (O1))
Program Officer
Brown, Martin L
Project Start
1999-06-01
Project End
2002-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
2
Fiscal Year
2000
Total Cost
$5,091,618
Indirect Cost

  Institution

Name
Center for Health Studies
Department
Type
DUNS #
078198520
City
Seattle
State
WA
Country
United States
Zip Code
98101

  Publications

Punglia, Rinaa S; Jiang, Wei; Lipsitz, Stuart R et al. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat 167:751-759
Lieu, Tracy A; Ray, G Thomas; Prausnitz, Stephanie R et al. (2017) Oncologist and organizational factors associated with variation in breast cancer multigene testing. Breast Cancer Res Treat 163:167-176
Hassett, Michael J; Uno, Hajime; Cronin, Angel M et al. (2017) Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol 49:186-194
Kimmick, Gretchen G; Major, Brittny; Clapp, Jonathan et al. (2017) Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Res Treat 163:391-398
Buist, Diana S M; Field, Terry S; Banegas, Matthew P et al. (2017) Training in the Conduct of Population-Based Multi-Site and Multi-Disciplinary Studies: the Cancer Research Network's Scholars Program. J Cancer Educ 32:283-292
Engmann, Natalie J; Ergas, Isaac J; Yao, Song et al. (2017) Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev 26:1466-1469
Yao, Song; Zhang, Yali; Tang, Li et al. (2017) Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat 161:501-513
Yao, Song; Kwan, Marilyn L; Ergas, Isaac J et al. (2017) Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol 3:351-357
Mazor, Kathleen M; Rubin, Donald L; Roblin, Douglas W et al. (2016) Health literacy-listening skill and patient questions following cancer prevention and screening discussions. Health Expect 19:920-34
Walsh, Kathleen; Ryan, Jamie; Daraiseh, Nancy et al. (2016) Errors and Nonadherence in Pediatric Oral Chemotherapy Use. Oncology 91:231-236

Showing the most recent 10 out of 188 publications